KOP THERAPEUTICS

KOP Therapeutics is a biotechnology company headquartered in Vancouver, BC Canada, in partnership with Thomas Jefferson University - Sidney Kimmel Cancer Center located in Philadelphia, Pennsylvania, U.S.A... KOP Therapeutics' unique and novel drug design targets biomolecules generated on the cell surface of most cancers including those cells that are resistant to current cancer therapies. Leaving the normal healthy cells intact, the KOP Drug is designed to treat cancer by targeting, blocking and silencing the cancer genes with minimal side effects and preventing cancer recurrences. With the alarming escalation of new cancer cases in 2021 estimated at 1,700,000 in the US alone, KOP Therapeutics is committed to finding the solution through financing the development and commercialization of our KOP Targeted Cell Based Cancer Therapy Platform... KOP is partnering with Thomas Jefferson University to develop new cancer therapies trough an exclusive global technology license agreement. The..

Also known as: KOP Therapeutics Corp.

Primary location: Vancouver